CaulfieldT.Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrollment. Health Law Rev2005; 13: 58–61.
2.
GelinasLLynchHFBiererBE, et al. When clinical trials compete: prioritising study recruitment. J Med Ethics2017; 43(12): 803–809.
3.
PaquetteMKelecevicJSchwartzL, et al. Ethical issues in competing clinical trials. Contemp Clin Trials Commun2019; 14: 100352.
4.
MeyerMGelinasLBiererB, et al. An ethics framework for consolidating and prioritizing COVID-19 clinical trials. Clin Trials (in press).
5.
EmanuelEJWendlerDGradyC.What makes clinical research ethical?JAMA2000; 283: 2701–2711.
6.
Spector-BagdadyKHigginsPDRAaronsonKD, et al. Coronavirus disease 2019 (COVID-19) clinical trial oversight at a major academic medical center: approach of Michigan medicine. Clin Infect Dis2020; 71: 2187–2190.
7.
WeinickRMHasnain-WyniaR.Quality improvement efforts under health reform: how to ensure that they help reduce disparities—not increase them. Health Aff (Millwood)2011; 30(10): 1837–1843.
8.
MbuagbawLAvesTSheaB, et al. Considerations and guidance in designing equity-relevant clinical trials. Int J Equity Health2017; 16(1): 93
9.
HartmanDHeatonPCammackN, et al. Clinical trials in the pandemic age: what is fit for purpose. Gates Open Res2020; 4: 58.
10.
ChangTSDingYFreundMK, et al. Prior diagnoses and medications as risk factors for COVID-19 in a Los Angeles Health System. Medrxiv. Epub Ahead of Print 4 July 2020. DOI: 10.1101/2020.07.03.20145581
11.
SimpsonE.The interpretation of interaction in contingency tables. J R Stat Soc Series B Stat Methodol1951; 13: 238–241
12.
Community Engagement Alliance (CEAL) Against COVID-19 Disparities. National Institutes of Health, https://covid19community.nih.gov/ (2020, accessed 7 December 2020).
